These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Review of the status and control of foot and mouth disease in sub-Saharan Africa. Vosloo W; Bastos AD; Sangare O; Hargreaves SK; Thomson GR Rev Sci Tech; 2002 Dec; 21(3):437-49. PubMed ID: 12523685 [TBL] [Abstract][Full Text] [Related]
3. A review of the status of foot and mouth disease in South-East Asia and approaches to control and eradication. Gleeson LJ Rev Sci Tech; 2002 Dec; 21(3):465-75. PubMed ID: 12530354 [TBL] [Abstract][Full Text] [Related]
4. Review of the Global Distribution of Foot-and-Mouth Disease Virus from 2007 to 2014. Brito BP; Rodriguez LL; Hammond JM; Pinto J; Perez AM Transbound Emerg Dis; 2017 Apr; 64(2):316-332. PubMed ID: 25996568 [TBL] [Abstract][Full Text] [Related]
5. Patterns of spread and persistence of foot-and-mouth disease types A, O and Asia-1 in Turkey: a meta-population approach. Gilbert M; Aktas S; Mohammed H; Roeder P; Sumption K; Tufan M; Slingenbergh J Epidemiol Infect; 2005 Jun; 133(3):537-45. PubMed ID: 15962561 [TBL] [Abstract][Full Text] [Related]
6. Generation of monoclonal antibodies against foot-and-mouth disease virus SAT 2 and the development of a lateral flow strip test for virus detection. Yang M; Mudabuka B; Quizon K; Nfon C Transbound Emerg Dis; 2019 May; 66(3):1158-1166. PubMed ID: 30462886 [TBL] [Abstract][Full Text] [Related]
7. The evolution and phylodynamics of serotype A and SAT2 foot-and-mouth disease viruses in endemic regions of Africa. Lycett S; Tanya VN; Hall M; King DP; Mazeri S; Mioulet V; Knowles NJ; Wadsworth J; Bachanek-Bankowska K; Ngu Ngwa V; Morgan KL; Bronsvoort BMC Sci Rep; 2019 Apr; 9(1):5614. PubMed ID: 30948742 [TBL] [Abstract][Full Text] [Related]
8. Challenges for Serology-Based Characterization of Foot-and-Mouth Disease Outbreaks in Endemic Areas; Identification of Two Separate Lineages of Serotype O FMDV in Uganda in 2011. Namatovu A; Belsham GJ; Ayebazibwe C; Dhikusooka MT; Wekesa SN; Siegismund HR; Muwanika VB; Tjørnehøj K Transbound Emerg Dis; 2015 Oct; 62(5):522-34. PubMed ID: 24118785 [TBL] [Abstract][Full Text] [Related]
9. Emergence of foot-and-mouth disease virus SAT 2 in Egypt during 2012. Ahmed HA; Salem SA; Habashi AR; Arafa AA; Aggour MG; Salem GH; Gaber AS; Selem O; Abdelkader SH; Knowles NJ; Madi M; Valdazo-González B; Wadsworth J; Hutchings GH; Mioulet V; Hammond JM; King DP Transbound Emerg Dis; 2012 Dec; 59(6):476-81. PubMed ID: 23025522 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of novel inactivated vaccines for the SAT 1, SAT 2 and SAT 3 serotypes of foot-and-mouth disease in pigs. Jo HE; You SH; Choi JH; Ko MK; Shin SH; Song J; Jo H; Lee MJ; Kim SM; Kim B; Park JH Virol J; 2019 Dec; 16(1):156. PubMed ID: 31842907 [TBL] [Abstract][Full Text] [Related]
12. Spatial and temporal distribution of foot-and-mouth disease in four districts situated along the Uganda-Tanzania border: Implications for cross-border efforts in disease control. Kerfua SD; Shirima G; Kusiluka L; Ayebazibwe C; Mwebe R; Cleaveland S; Haydon D Onderstepoort J Vet Res; 2018 Aug; 85(1):e1-e8. PubMed ID: 30198279 [TBL] [Abstract][Full Text] [Related]
13. Development of vaccines toward the global control and eradication of foot-and-mouth disease. Rodriguez LL; Gay CG Expert Rev Vaccines; 2011 Mar; 10(3):377-87. PubMed ID: 21434805 [TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of foot-and-mouth disease virus in cattle herds raised in Maasai Mara ecosystem in Kenya. Nthiwa D; Bett B; Odongo D; Kenya E; Wainaina M; Grazioli S; Foglia E; Brocchi E; Alonso S Prev Vet Med; 2020 Mar; 176():104929. PubMed ID: 32105863 [TBL] [Abstract][Full Text] [Related]
15. Serological evidence indicates that foot-and-mouth disease virus serotype O, C and SAT1 are most dominant in eritrea. Tekleghiorghis T; Moormann RJ; Weerdmeester K; Dekker A Transbound Emerg Dis; 2014 Dec; 61(6):e83-8. PubMed ID: 23480728 [TBL] [Abstract][Full Text] [Related]
16. Development and validation of a foot-and-mouth disease virus SAT serotype-specific 3ABC assay to differentiate infected from vaccinated animals. Chitray M; Grazioli S; Willems T; Tshabalala T; De Vleeschauwer A; Esterhuysen JJ; Brocchi E; De Clercq K; Maree FF J Virol Methods; 2018 May; 255():44-51. PubMed ID: 29428400 [TBL] [Abstract][Full Text] [Related]
17. A review of foot and mouth disease in Nepal. Ferris NP; Donaldson AI; Shrestha RM; Kitching RP Rev Sci Tech; 1992 Sep; 11(3):685-98. PubMed ID: 1335303 [TBL] [Abstract][Full Text] [Related]
18. Outbreak investigations of foot and mouth disease virus in Nepal between 2010 and 2015 in the context of historical serotype occurrence. Adhikari G; Acharya KP; Upadhyay M; Raut R; Kaphle K; Khanal T; Bertram MR; Stenfeldt C; Arzt J Vet Med Sci; 2018 Nov; 4(4):304-314. PubMed ID: 30198633 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of laboratory tests for SAT serotypes of foot-and-mouth disease virus with specimens collected from convalescent cattle in Zimbabwe. Sammin DJ; Paton DJ; Parida S; Ferris NP; Hutchings GH; Reid SM; Shaw AE; Holmes C; Gibson D; Corteyn M; Knowles NJ; Valarcher JF; Hamblin PA; Fleming L; Gwaze G; Sumption KJ Vet Rec; 2007 May; 160(19):647-54. PubMed ID: 17496271 [TBL] [Abstract][Full Text] [Related]
20. Incidence and distribution of foot-and-mouth disease in Asia, Africa and South America; combining expert opinion, official disease information and livestock populations to assist risk assessment. Sumption K; Rweyemamu M; Wint W Transbound Emerg Dis; 2008; 55(1):5-13. PubMed ID: 18397505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]